CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dill-Russell, P. C.
Right arrow Articles by Ravalia, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dill-Russell, P. C.
Right arrow Articles by Ravalia, A.
Canadian Journal of Anesthesia 49:757 (2002)
© Canadian Anesthesiologists' Society, 2002


Correspondence

Use of a remifentanil PCA for a patient with multiple rib fractures

Patrick Colm Dill-Russell, MRCP FRCA, Lenny Ng, MBBCH FRCA and Abdulsatar Ravalia, FRCA

London, UK

To the Editor:

A 48-yr-old woman, weighing 55 kg, fell off her horse and was admitted to our High Dependency Unit with fractures of L1–L3 transverse processes, fractured left second to eighth ribs and hemopneumothorax requiring a chest drain and regular chest physiotherapy.

The patient was given regular oral paracetamol 1 g six hourly and tramadol 50 mg at six hourly intervals and started on a morphine patient-controlled analgesia (PCA) pump, programmed to give 1 mg boluses with a five-minute lockout time. However, the patient complained of bad dreams, paranoia, drowsiness and nausea while using it. In view of this the morphine in the PCA was changed to remifentanil on the fourth day. A concentration of 25 µg•mL-1 was prepared and administered as a PCA pump with boluses of 25 µg (approximately 0.5 µg•kg-1) using a five-minute lockout time. On day six a continuous infusion of 50 µg•hr-1 (approximately 1 µg•kg-1•hr-1) was added as a background infusion to the PCA. The patient reported feeling less nauseated, and claimed the bad dreams and paranoia had stopped. The daily mean sedation and nausea scores improved while on the remifentanil PCA.

No bradycardias or desaturations were observed in our patient. We suggest that the use of remifentanil as a PCA be considered in patients where rapid control of analgesia is required, e.g., for chest physiotherapy, and the accumulative sedative and respiratory depressant effects of longer-acting opiates are undesirable.


View this table:
[in this window]
[in a new window]
 
TABLE Daily pain, sedation and nausea scores with morphine and then remifentanil
 




This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dill-Russell, P. C.
Right arrow Articles by Ravalia, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dill-Russell, P. C.
Right arrow Articles by Ravalia, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS